Impact of polyunsaturated fatty acids on patient-important outcomes in children and adolescents with autism spectrum disorder: a systematic review
Authors:
- on behalf of the ISACA guideline working groupOGon behalf of the ISACA guideline working group
- Franco De CrescenzoFCFranco De Crescenzo
- Gian Loreto D’aLòGian Loreto D’aLò
- Gian Paolo MorganoGMGian Paolo Morgano
- Silvia MinozziSMSilvia Minozzi
- Zuzana MitrovaZMZuzana Mitrova
- Rosella SaulleRSRosella Saulle
- Fabio CrucianiFCFabio Cruciani
- Francesca FulceriFFFrancesca Fulceri
- Marina DavoliMDMarina Davoli
- Maria Luisa ScattoniMSMaria Luisa Scattoni
- Francesco NardocciFNFrancesco Nardocci
Open Access
- 17 February 2020
- journal article
- review article
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 18 (1) , 1-12
Abstract
Background: Recent randomized controlled trials (RCTs) claimed PUFAs to be effective for autism spectrum disorder (ASD) but international guidelines have not considered yet this body of evidence. Our aim was to assess the effectiveness of PUFAs in children and adolescents with ASD, for the Italian national guidelines on the management of ASD in children and adolescents.Methods: We performed a systematic review and meta-analysis of RCTs comparing PUFAs versus placebo or a healthy diet for the treatment of ASD in children and adolescents. The outcomes considered were deemed by the guideline panel to be highly relevant to children and adolescents with ASD and to their caregivers. The outcomes included hyperactivity, quality of sleep, self-harm, aggression, irritability, anxiety, attention, adaptive functioning, social interaction, restricted and repetitive interests and behavior, communication, hyperactivity and disruptive behaviors coexistent with core symptoms. The risk of bias of the included studies was assessed with the Cochrane tool, and the rating of the confidence in the effect estimates according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach.Results: We included 9 studies with 405 participants. The strength of evidence ranged from low to very low. Six studies included preschoolers and school-age children, three studies included both children and adolescents. The majority of participants were males (83.8%), with a mean age of 6.7 years. PUFAs were superior compared to placebo in reducing anxiety in individuals with ASD (SMD -1.01, 95% CI − 1.86 to − 0.17; very low certainty of evidence). Moreover, PUFAs worsened quality of sleep compared to a healthy diet (SMD 1.11, 95% CI 0.21 to 2.00; very low certainty of evidence). PUFAs were not better than placebo in reducing aggression, hyperactivity, adaptive functioning, irritability, restricted and repetitive interests and behaviors and communication. Effects on some critical outcomes such as sleep, self-harm and disruptive behavior are currently unknown. The main limitations were the small number of participants included in the RCTs and the dosage which varied greatly (from 200 mg/day to 1540 mg/day), making it difficult to address causal inference.Conclusions: PUFAs did not show evidence of effect in children and adolescents with ASD and the certainty of evidence as measured with the GRADE was low to very low. Further research is needed on this topic because the available evidence is inconclusive.Keywords
This publication has 47 references indexed in Scilit:
- Parental Perspectives on Use, Benefits, and Physician Knowledge of Complementary and Alternative Medicine in Children with Autistic Disorder and Attention-Deficit/Hyperactivity DisorderThe Journal of Alternative and Complementary Medicine, 2013
- Polyunsaturated Fatty Acids in ChildrenPediatric Gastroenterology, Hepatology & Nutrition, 2013
- Effects of Large Doses of Arachidonic Acid Added to Docosahexaenoic Acid on Social Impairment in Individuals With Autism Spectrum DisordersJournal of Clinical Psychopharmacology, 2012
- A Pilot Randomized Controlled Trial of Omega-3 Fatty Acids for Autism Spectrum DisorderJournal of Autism and Developmental Disorders, 2010
- Omega 3 Fatty Acid Treatment in AutismJournal of Child and Adolescent Psychopharmacology, 2009
- Behavioral Effects of Omega-3 Fatty Acid Supplementation in Young Adults with Severe Autism: An Open Label StudyArchives of Medical Research, 2008
- Presenting Results and ‘Summary of Findings’ Tables2008
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Safety Considerations with Omega-3 Fatty Acid TherapyThe American Journal of Cardiology, 2007
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986